Longevity Health Holdings, Inc. (XAGE) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Longevity Health Holdings, Inc. (XAGE) stock forecast summary
Our AI ranks Longevity Health Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Longevity Health Holdings, Inc. is a small-cap company with a market capitalization of $280K. It ranks number 6 by market capitalization among the 6 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics issuers in our coverage with a current forecast.
For XAGE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 289 forecast dates between 2023-11-17 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 4.0%, measured on 332 forecast dates between 2023-11-17 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, XAGE included.
Follow XAGE freeXAGE price chart and AI forecast
How XAGE ranks among 5185 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Longevity Health Holdings, Inc. (XAGE) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics peers listed below that report each metric.
Valuation & Market
| Metric | XAGE | Rank |
|---|---|---|
| Market Cap | $280K | 6/6 |
| EPS | $-4.06 | – |
| Revenue/Share | $0.68 | – |
Profitability & Margins
| Metric | XAGE | Rank |
|---|---|---|
| ROA | -647.0% | 5/5 |
| ROIC | 67.9% | 1/5 |
| Gross Margin | 59.0% | 1/6 |
| Operating Margin | -343.6% | 6/6 |
| Net Margin | -404.8% | 5/5 |
| EBT Margin | -402.7% | 6/6 |
| Tax Rate | -0.5% | – |
Financial Health
| Metric | XAGE | Rank |
|---|---|---|
| Current Ratio | 0.07x | 5/5 |
| Quick Ratio | 0.01x | 5/5 |
| Interest Coverage | -336.3x | 5/5 |
| Working Capital | -$9M | 4/5 |
Cash Flow
| Metric | XAGE | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 6/6 |
Operational Efficiency
| Metric | XAGE | Rank |
|---|---|---|
| Asset Turnover | 1.60x | 2/6 |
| Receivables Turnover | 86.3x | 1/5 |
| Inventory Turnover | 1.1x | 5/5 |
| Fixed Assets Turnover | 22.3x | 1/5 |
| Days Sales Outstanding | 4 days | 5/5 |
| Days Inventory | 320 days | 1/5 |
| Payables Period | 2659 days | 1/5 |
| Cash Conversion Cycle | -2335 days | 5/5 |
Income Statement
| Metric | XAGE | Rank |
|---|---|---|
| Total Revenue | $2M | 6/6 |
| Operating Income | -$6M | 6/6 |
| Net Income | -$7M | 5/5 |
| R&D Expense | $490K | – |
| Cost of Goods Sold | $690K | 6/6 |
Dividend & Shareholder Information
| Metric | XAGE | Rank |
|---|---|---|
| Shares Outstanding | 2M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $710K | 67.0% of assets |
| Cash & Short-term Investments | $40K | 3.8% of assets |
| Accounts Receivable | $20K | 1.9% of assets |
| Inventory | $610K | 57.5% of assets |
| Total Liabilities | $10M | |
| Short-term Debt | $5M |
XAGE quarterly financials and insider trading
Longevity Health Holdings, Inc. (XAGE) industry peers
Companies classified under the same SEC industry code as Longevity Health Holdings, Inc. (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere XAGE sits on the market map
Longevity Health Holdings, Inc. (XAGE) stock news
Loading...
Longevity Health Holdings, Inc. (XAGE) stock forecast FAQ
What is the Longevity Health Holdings, Inc. (XAGE) stock forecast?
Our AI ranks Longevity Health Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Longevity Health Holdings, Inc. stock predictions?
For XAGE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 289 forecast dates between 2023-11-17 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 4.0%, measured on 332 forecast dates between 2023-11-17 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Longevity Health Holdings, Inc. forecasts updated?
Longevity Health Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Longevity Health Holdings, Inc.'s industry peers?
6 issuers in our coverage, XAGE included, share the SEC industry code Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics. The largest are: Procter & Gamble Co (PG), Unilever Plc (UL), Ecolab Inc. (ECL), Church & Dwight Co Inc /De/ (CHD), Stepan Co (SCL).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.